Liabilities / Assets
99th percentile
Higher debt load relative to assets than 99% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
4.13x
Liabilities / Revenue
77th percentile
Higher debt load relative to revenue than 77% of similar nonprofits.
Net Margin
7th percentile
Higher net margin than 7% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
1st percentile
Faster asset growth than 1% of similar nonprofits.
Revenue Growth
16th percentile
Faster revenue growth than 16% of similar nonprofits.
Balance Sheet
Assets
Down$229,805
Down $344,258 (-60%) from 2010
Net Assets
Down-$718,967
Down $687,389 (-2177%) from 2010
Liabilities
Up$948,772
Up $343,131 (+57%) from 2010
Revenue And Expenses
Revenue
Down$1,707,895
Down $527,592 (-24%) from 2010
Expenses
Down$2,395,284
Down $193,742 (-7.5%) from 2010
Net Income
Down-$687,389
Down $333,850 (-94%) from 2010
Historical Trend
Filing Detail Status
This 2011 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2011 to Dec 31, 2011
Mission and Program Overview
Mission
To facilitate the design, development, manufacture and distribution of vaccine technologies and specific vaccines for poorer nations and third world countries.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2011 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $229,805
- Liabilities
- $948,772
- Net assets
- -$718,967
- Revenue
- $1,707,895
- Expenses
- $2,395,284
- Net income
- -$687,389